BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Zadikoff C, Fox SH, Tang-Wai DF, Thomsen T, de Bie RM, Wadia P, Miyasaki J, Duff-Canning S, Lang AE, Marras C. A comparison of the mini mental state exam to the Montreal cognitive assessment in identifying cognitive deficits in Parkinson's disease. Mov Disord. 2008;23:297-299. [PMID: 18044697 DOI: 10.1002/mds.21837] [Cited by in Crossref: 207] [Cited by in F6Publishing: 223] [Article Influence: 13.8] [Reference Citation Analysis]
Number Citing Articles
1 Lang CE, Holleran CL, Strube MJ, Ellis TD, Newman CA, Fahey M, DeAngelis TR, Nordahl TJ, Reisman DS, Earhart GM, Lohse KR, Bland MD. Improvement in the Capacity for Activity Versus Improvement in Performance of Activity in Daily Life During Outpatient Rehabilitation. J Neurol Phys Ther 2023;47:16-25. [PMID: 35930404 DOI: 10.1097/NPT.0000000000000413] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
2 Roheger M, Xu H, Hoang MT, Eriksdotter M, Garcia-Ptacek S. Conversion Between the Mini-Mental State Examination and the Montreal Cognitive Assessment for Patients With Different Forms of Dementia. J Am Med Dir Assoc 2022;23:1986-1989.e1. [PMID: 35561758 DOI: 10.1016/j.jamda.2022.03.018] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
3 Li X, Geng D, Wang S, Sun G. Aerobic exercises and cognitive function in post-stroke patients: A systematic review with meta-analysis. Medicine 2022;101:e31121. [DOI: 10.1097/md.0000000000031121] [Reference Citation Analysis]
4 Ciccarelli N, Colombo B, Pepe F, Magni E, Antonietti A, Silveri MC. Cognitive reserve: a multidimensional protective factor in Parkinson’s disease related cognitive impairment. Aging, Neuropsychology, and Cognition 2022;29:687-702. [DOI: 10.1080/13825585.2021.1892026] [Reference Citation Analysis]
5 Holmes AA, Tripathi S, Katz E, Mondesire-crump I, Mahajan R, Ritter A, Arroyo-gallego T, Giancardo L. A novel framework to estimate cognitive impairment via finger interaction with digital devices. Brain Communications 2022;4. [DOI: 10.1093/braincomms/fcac194] [Reference Citation Analysis]
6 Ortelli P, Ferrazzoli D, Versace V, Cian V, Zarucchi M, Gusmeroli A, Canesi M, Frazzitta G, Volpe D, Ricciardi L, Nardone R, Ruffini I, Saltuari L, Sebastianelli L, Baranzini D, Maestri R. Optimization of cognitive assessment in Parkinsonisms by applying artificial intelligence to a comprehensive screening test. NPJ Parkinsons Dis 2022;8:42. [PMID: 35410449 DOI: 10.1038/s41531-022-00304-z] [Reference Citation Analysis]
7 Simon OB, Rojas DC, Ghosh D, Yang X, Rogers SE, Martin CS, Holden SK, Kluger BM, Buard I. Profiling Parkinson's disease cognitive phenotypes via resting-state magnetoencephalography. J Neurophysiol 2022;127:279-89. [PMID: 34936515 DOI: 10.1152/jn.00316.2021] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
8 Wang L, Zhou C, Cheng W, Rolls ET, Huang P, Ma N, Liu Y, Zhang Y, Guan X, Guo T, Wu J, Gao T, Xuan M, Gu Q, Xu X, Zhang B, Gong W, Du J, Zhang W, Feng J, Zhang M. Dopamine depletion and subcortical dysfunction disrupt cortical synchronization and metastability affecting cognitive function in Parkinson's disease. Hum Brain Mapp 2021. [PMID: 34904766 DOI: 10.1002/hbm.25745] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
9 Castelli MB, Alonso-recio L, Carvajal F, Serrano JM. Does the Montreal Cognitive Assessment (MoCA) identify cognitive impairment profiles in Parkinson’s disease? An exploratory study. Applied Neuropsychology: Adult 2021. [DOI: 10.1080/23279095.2021.2011727] [Reference Citation Analysis]
10 Utne I, Løyland B, Grov EK, Rasmussen HL, Torstveit AH, Paul SM, Ritchie C, Lindemann K, Vistad I, Rodríguez-Aranda C, Miaskowski C. Age-related differences in self-report and objective measures of cognitive function in older patients prior to chemotherapy. Nurs Open 2021. [PMID: 34878233 DOI: 10.1002/nop2.1141] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
11 Simon OB, Buard I, Rojas DC, Holden SK, Kluger BM, Ghosh D. A novel approach to understanding Parkinsonian cognitive decline using minimum spanning trees, edge cutting, and magnetoencephalography. Sci Rep 2021;11:19704. [PMID: 34611218 DOI: 10.1038/s41598-021-99167-2] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
12 García AM, Arias-Vergara T, C Vasquez-Correa J, Nöth E, Schuster M, Welch AE, Bocanegra Y, Baena A, Orozco-Arroyave JR. Cognitive Determinants of Dysarthria in Parkinson's Disease: An Automated Machine Learning Approach. Mov Disord 2021. [PMID: 34390508 DOI: 10.1002/mds.28751] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 4.5] [Reference Citation Analysis]
13 Oxtoby NP, Leyland LA, Aksman LM, Thomas GEC, Bunting EL, Wijeratne PA, Young AL, Zarkali A, Tan MMX, Bremner FD, Keane PA, Morris HR, Schrag AE, Alexander DC, Weil RS. Sequence of clinical and neurodegeneration events in Parkinson's disease progression. Brain 2021;144:975-88. [PMID: 33543247 DOI: 10.1093/brain/awaa461] [Cited by in Crossref: 18] [Cited by in F6Publishing: 20] [Article Influence: 9.0] [Reference Citation Analysis]
14 Snyder A, Gruber-Baldini AL, Rainer von Coelln F, Savitt JM, Reich SG, Armstrong MJ, Shulman LM. Comparison of Mini-Mental State Examination and Montreal Cognitive Assessment Ratings Across Levels of Parkinson's Disease Severity. J Parkinsons Dis 2021. [PMID: 34366371 DOI: 10.3233/JPD-212705] [Reference Citation Analysis]
15 Wu Y, Zhang Y, Yuan X, Guo J, Gao X. Influence of education level on MMSE and MoCA scores of elderly inpatients. Appl Neuropsychol Adult 2021;:1-5. [PMID: 34266325 DOI: 10.1080/23279095.2021.1952588] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
16 van Wamelen DJ, Sauerbier A, Leta V, Rodriguez-Blazquez C, Falup-Pecurariu C, Rodriguez-Violante M, Rizos A, Tsuboi Y, Metta V, Bhidayasiri R, Bhattacharya K, Borgohain R, Prashanth LK, Rosales R, Lewis S, Fung V, Behari M, Goyal V, Kishore A, Lloret SP, Martinez-Martin P, Chaudhuri KR. Cross-sectional analysis of the Parkinson's disease Non-motor International Longitudinal Study baseline non-motor characteristics, geographical distribution and impact on quality of life. Sci Rep 2021;11:9611. [PMID: 33953218 DOI: 10.1038/s41598-021-88651-4] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 4.0] [Reference Citation Analysis]
17 Sousa NMF, Neri ACDM, Brandi IV, Brucki SMD. Impact of cognitive intervention on cognitive symptoms and quality of life in idiopathic Parkinson's disease: a randomized and controlled study. Dement Neuropsychol 2021;15:51-9. [PMID: 33907597 DOI: 10.1590/1980-57642021dn15-010005] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
18 Katz MJ, Wang C, Nester CO, Derby CA, Zimmerman ME, Lipton RB, Sliwinski MJ, Rabin LA. T-MoCA: A valid phone screen for cognitive impairment in diverse community samples. Alzheimers Dement (Amst) 2021;13:e12144. [PMID: 33598528 DOI: 10.1002/dad2.12144] [Cited by in Crossref: 11] [Cited by in F6Publishing: 15] [Article Influence: 5.5] [Reference Citation Analysis]
19 Sivasankaran SK, Bharadwaj R, Balasubramanian V. Comparative Assessment of Mini-Mental State Examination in Bus Drivers for On-Road and Simulator Study Conditions. Design Science and Innovation 2021. [DOI: 10.1007/978-981-15-9054-2_66] [Reference Citation Analysis]
20 Jankovic J, Hallett M, Okun MS, Comella C, Fahn S, Goldman J. Parkinsonism. Principles and Practice of Movement Disorders 2021. [DOI: 10.1016/b978-0-323-31071-0.00004-4] [Reference Citation Analysis]
21 Liu Y, Wu L, Yang C, Xian W, Zheng Y, Zhang C, Hong G, Jiang L, Yang Z, Pei Z, Liu J, Chen L. The white matter hyperintensities within the cholinergic pathways and cognitive performance in patients with Parkinson's disease after bilateral STN DBS. J Neurol Sci 2020;418:117121. [PMID: 32950863 DOI: 10.1016/j.jns.2020.117121] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
22 Lees T, Maharaj S, Kalatzis G, Nassif NT, Newton PJ, Lal S. Electroencephalographic prediction of global and domain specific cognitive performance of clinically active Australian Nurses. Physiol Meas 2020;41:095001. [PMID: 33021231 DOI: 10.1088/1361-6579/abb12a] [Reference Citation Analysis]
23 Ashburn A, Pickering R, McIntosh E, Hulbert S, Rochester L, Roberts HC, Nieuwboer A, Kunkel D, Goodwin VA, Lamb SE, Ballinger C, Seymour KC. Exercise- and strategy-based physiotherapy-delivered intervention for preventing repeat falls in people with Parkinson's: the PDSAFE RCT. Health Technol Assess 2019;23:1-150. [PMID: 31339100 DOI: 10.3310/hta23360] [Cited by in Crossref: 25] [Cited by in F6Publishing: 26] [Article Influence: 8.3] [Reference Citation Analysis]
24 Freilich BM, Feirsen N, Welton EI, Mowrey WB, Rubinstein TB. Validation of the Attention, Memory, and Frontal Abilities Screening Test (AMFAST). Assessment 2020;27:1502-1514. [DOI: 10.1177/1073191118822734] [Reference Citation Analysis]
25 Benge JF, Kiselica AM. Rapid communication: Preliminary validation of a telephone adapted Montreal Cognitive Assessment for the identification of mild cognitive impairment in Parkinson's disease. Clin Neuropsychol 2021;35:133-47. [PMID: 32779959 DOI: 10.1080/13854046.2020.1801848] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]
26 van Wamelen DJ, Taddei RN, Calvano A, Titova N, Leta V, Shtuchniy I, Jenner P, Martinez-martin P, Katunina E, Chaudhuri KR. Serum Uric Acid Levels and Non-Motor Symptoms in Parkinson’s Disease. JPD 2020;10:1003-10. [DOI: 10.3233/jpd-201988] [Cited by in Crossref: 8] [Cited by in F6Publishing: 10] [Article Influence: 2.7] [Reference Citation Analysis]
27 Mazancova AF, Růžička E, Jech R, Bezdicek O. Test the Best: Classification Accuracies of Four Cognitive Rating Scales for Parkinson's Disease Mild Cognitive Impairment. Arch Clin Neuropsychol 2020:acaa039. [PMID: 32681175 DOI: 10.1093/arclin/acaa039] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 4.0] [Reference Citation Analysis]
28 Mordenfeld N, Gayus N, Azmon M, Guri-Twito O, Yahalom Peri T, Natovich R, Cukierman-Yaffe T. Determining the Optimal Cognitive Screening Tool in Older People With Diabetes. Front Endocrinol (Lausanne) 2020;11:322. [PMID: 32528414 DOI: 10.3389/fendo.2020.00322] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
29 Mahmoudi Asl A, Mehdizadeh M, Raeesi Roudbari P, Mehdizadeh H, Habibi SA, Niazi Khatoon J, Taghizadeh G. Staging of cognitive impairment in Parkinson's disease: validity of Quick Dementia Rating System. Disabil Rehabil 2020;:1-8. [PMID: 32374182 DOI: 10.1080/09638288.2020.1755728] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 0.7] [Reference Citation Analysis]
30 Scheffels JF, Fröhlich L, Kalbe E, Kessler J. Concordance of Mini-Mental State Examination, Montreal Cognitive Assessment and Parkinson Neuropsychometric Dementia Assessment in the classification of cognitive performance in Parkinson's disease. Journal of the Neurological Sciences 2020;412:116735. [DOI: 10.1016/j.jns.2020.116735] [Cited by in Crossref: 8] [Cited by in F6Publishing: 4] [Article Influence: 2.7] [Reference Citation Analysis]
31 Chuang YH, Lu AT, Paul KC, Folle AD, Bronstein JM, Bordelon Y, Horvath S, Ritz B. Longitudinal Epigenome-Wide Methylation Study of Cognitive Decline and Motor Progression in Parkinson's Disease. J Parkinsons Dis 2019;9:389-400. [PMID: 30958317 DOI: 10.3233/JPD-181549] [Cited by in Crossref: 21] [Cited by in F6Publishing: 23] [Article Influence: 7.0] [Reference Citation Analysis]
32 Ardenghi LG, Signorini AV, Maahs GS, Selaimen F, Deutsch KM, Dornelles S, Rieder CRM. Deglutition Impairment during Dual Task in Parkinson Disease Is Associated with Cognitive Status. Int Arch Otorhinolaryngol 2021;25:e41-7. [PMID: 33542750 DOI: 10.1055/s-0039-3402440] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.7] [Reference Citation Analysis]
33 van Wamelen DJ, Leta V, Johnson J, Ocampo CL, Podlewska AM, Rukavina K, Rizos A, Martinez-Martin P, Chaudhuri KR. Drooling in Parkinson's Disease: Prevalence and Progression from the Non-motor International Longitudinal Study. Dysphagia 2020;35:955-61. [PMID: 32130515 DOI: 10.1007/s00455-020-10102-5] [Cited by in Crossref: 29] [Cited by in F6Publishing: 21] [Article Influence: 9.7] [Reference Citation Analysis]
34 Karaaslan Ö, Hamamcı M. Cognitive impairment profile differences in patients with psychogenic non-epileptic seizures and epilepsy patients with generalized seizures. Neurological Research 2020;42:179-88. [DOI: 10.1080/01616412.2020.1716468] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]
35 Cahn-Hidalgo D, Estes PW, Benabou R. Validity, reliability, and psychometric properties of a computerized, cognitive assessment test (Cognivue®). World J Psychiatr 2020; 10(1): 1-11 [PMID: 31956523 DOI: 10.5498/wjp.v10.i1.1] [Cited by in CrossRef: 9] [Cited by in F6Publishing: 9] [Article Influence: 3.0] [Reference Citation Analysis]
36 Bakeberg M, Riley M, Byrnes M, Mastaglia FL, Anderton RS. Clinically assessing cognitive function in Parkinson's disease. Diagnosis and Management in Parkinson's Disease 2020. [DOI: 10.1016/b978-0-12-815946-0.00024-7] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
37 Blanco-Campal A, Diaz-Orueta U, Navarro-Prados AB, Burke T, Libon DJ, Lamar M. Features and psychometric properties of the Montreal Cognitive Assessment: Review and proposal of a process-based approach version (MoCA-PA). Appl Neuropsychol Adult 2021;28:658-72. [PMID: 31718290 DOI: 10.1080/23279095.2019.1681996] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 1.8] [Reference Citation Analysis]
38 Ringkøbing SP, Larsen IU, Jørgensen K, Vinther-Jensen T, Vogel A. Cognitive Screening Tests in Huntington Gene Mutation Carriers: Examining the Validity of the Mini-Mental State Examination and the Montreal Cognitive Assessment. J Huntingtons Dis 2020;9:59-68. [PMID: 31658065 DOI: 10.3233/JHD-190350] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 1.5] [Reference Citation Analysis]
39 Yakufujiang M, Higuchi Y, Aoyagi K, Yamamoto T, Abe M, Okahara Y, Izumi M, Nagano O, Yamanaka Y, Hirano S, Shiina A, Murata A, Iwadate Y. Predictive potential of preoperative electroencephalogram for neuropsychological change following subthalamic nucleus deep brain stimulation in Parkinson's disease. Acta Neurochir (Wien) 2019;161:2049-58. [PMID: 31278598 DOI: 10.1007/s00701-019-03991-5] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
40 Saunders-Pullman R, Mirelman A, Alcalay RN, Wang C, Ortega RA, Raymond D, Mejia-Santana H, Orbe-Reilly M, Johannes BA, Thaler A, Ozelius L, Orr-Urtreger A, Marder KS, Giladi N, Bressman SB; LRRK2 Ashkenazi Jewish Consortium. Progression in the LRRK2-Asssociated Parkinson Disease Population. JAMA Neurol 2018;75:312-9. [PMID: 29309488 DOI: 10.1001/jamaneurol.2017.4019] [Cited by in Crossref: 69] [Cited by in F6Publishing: 71] [Article Influence: 17.3] [Reference Citation Analysis]
41 Acaröz Candan S, Özcan TŞ. Dual-task interference during hand dexterity is a predictor for activities of daily living performance in Parkinson's disease. Parkinsonism & Related Disorders 2019;66:100-4. [DOI: 10.1016/j.parkreldis.2019.07.017] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 1.3] [Reference Citation Analysis]
42 Smith C, Malek N, Grosset K, Cullen B, Gentleman S, Grosset DG. Neuropathology of dementia in patients with Parkinson's disease: a systematic review of autopsy studies. J Neurol Neurosurg Psychiatry 2019;90:1234-43. [PMID: 31444276 DOI: 10.1136/jnnp-2019-321111] [Cited by in Crossref: 31] [Cited by in F6Publishing: 39] [Article Influence: 7.8] [Reference Citation Analysis]
43 Fastame MC, Hitchcott PK, Corona F, Pilloni G, Porta M, Pau M, Penna MP. Memory, Subjective Memory and Motor Functioning in Non-Demented Elders With and Without Parkinson's Disease. Eur J Psychol 2019;15:404-20. [PMID: 33574963 DOI: 10.5964/ejop.v15i2.1672] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
44 James RF, Khattar NK, Aljuboori ZS, Page PS, Shao EY, Carter LM, Meyer KS, Daniels MW, Craycroft J, Gaughen JR, Chaudry MI, Rai SN, Everhart DE, Simard JM. Continuous infusion of low-dose unfractionated heparin after aneurysmal subarachnoid hemorrhage: a preliminary study of cognitive outcomes. Journal of Neurosurgery 2019;130:1460-7. [DOI: 10.3171/2017.11.jns17894] [Cited by in Crossref: 12] [Cited by in F6Publishing: 15] [Article Influence: 3.0] [Reference Citation Analysis]
45 Chivers Seymour K, Pickering R, Rochester L, Roberts HC, Ballinger C, Hulbert S, Kunkel D, Marian IR, Fitton C, McIntosh E, Goodwin VA, Nieuwboer A, Lamb SE, Ashburn A. Multicentre, randomised controlled trial of PDSAFE, a physiotherapist-delivered fall prevention programme for people with Parkinson's. J Neurol Neurosurg Psychiatry 2019;90:774-82. [PMID: 30944149 DOI: 10.1136/jnnp-2018-319448] [Cited by in Crossref: 34] [Cited by in F6Publishing: 35] [Article Influence: 8.5] [Reference Citation Analysis]
46 Konstantopoulos K, Vogazianos P. Montreal Cognitive Assessment in a Greek sample of patients with multiple sclerosis: A validation study. Appl Neuropsychol Adult 2021;28:48-52. [PMID: 30939943 DOI: 10.1080/23279095.2019.1588123] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 0.5] [Reference Citation Analysis]
47 Rambeau A, Beauplet B, Laviec H, Licaj I, Leconte A, Chatel C, Le Bon P, Denhaerynck J, Clarisse B, Frenkiel N, Lange M, Joly F. Prospective comparison of the Montreal Cognitive Assessment (MoCA) and the Mini Mental State Examination (MMSE) in geriatric oncology. Journal of Geriatric Oncology 2019;10:235-40. [DOI: 10.1016/j.jgo.2018.08.003] [Cited by in Crossref: 18] [Cited by in F6Publishing: 18] [Article Influence: 4.5] [Reference Citation Analysis]
48 Badrkhahan SZ, Sikaroodi H, Sharifi F, Kouti L, Noroozian M. Validity and reliability of the Persian version of the Montreal Cognitive Assessment (MoCA-P) scale among subjects with Parkinson's disease. Appl Neuropsychol Adult 2020;27:431-9. [PMID: 30821505 DOI: 10.1080/23279095.2019.1565762] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 2.8] [Reference Citation Analysis]
49 Barnish M, Daley DJ, Deane KH, Clark AB, Gray RJ, Horton SM, Butterfint ZR, Myint PK. Cognitive profile and determinants of poor cognition in people without dementia in Parkinson's disease. Med J Islam Repub Iran 2019;33:1. [PMID: 31086780 DOI: 10.34171/mjiri.33.1] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
50 Kim H, Kim HK, Kim SY, Kim YI, Yoo HR, Jung IC. Cognitive improvement effects of electro-acupuncture for the treatment of MCI compared with Western medications: a systematic review and Meta-analysis. BMC Complement Altern Med 2019;19:13. [PMID: 30621676 DOI: 10.1186/s12906-018-2407-2] [Cited by in Crossref: 18] [Cited by in F6Publishing: 18] [Article Influence: 4.5] [Reference Citation Analysis]
51 Tröster AI, Abbott A. Movement Disorders with Dementia in Older Adults. Handbook on the Neuropsychology of Aging and Dementia 2019. [DOI: 10.1007/978-3-319-93497-6_34] [Reference Citation Analysis]
52 De Freitas TB, Leite PHW, Doná F, Pompeu JE, Swarowsky A, Torriani-pasin C. The effects of dual task gait and balance training in Parkinson’s disease: a systematic review. Physiotherapy Theory and Practice 2020;36:1088-96. [DOI: 10.1080/09593985.2018.1551455] [Cited by in Crossref: 23] [Cited by in F6Publishing: 19] [Article Influence: 4.6] [Reference Citation Analysis]
53 Eftekhari SS, Hejazi SA, Sharifipour E, Hejazi SF, Talebizadeh M, Mostafavi H, Yoosefee S, Neuroscience Research Center, Qom University of Medical Sciences, Qom, Iran, Neuroscience Research Center, Qom University of Medical Sciences, Qom, Iran, Neuroscience Research Center, Qom University of Medical Sciences, Qom, Iran, Dept. of Cardiology, Faculty of Medicine, Qom University of Medical Sciences, Qom, Iran, Neuroscience Research Center, Qom University of Medical Sciences, Qom, Iran, Dept. of Physiology and Pharmacology, Faculty of Medicine, Zanjan University of Medical Sciences, Zanjan, Iran, Neuroscience Research Center, Spiritual Health Research Center, Qom University of Medical Sciences, Qom, Iran. Cognitive Impairment in Patients with Coronary Artery Disease; Comparison of Montreal Cognitive Assessment (MoCA) and Mini Mental State Examination (MMSE). J Adv Med Biomed Res 2018;26:12-16. [DOI: 10.30699/jambs.26.119.12] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
54 Lees T, Chalmers T, Burton D, Zilberg E, Penzel T, Lal S, Lal S. Electroencephalography as a predictor of self-report fatigue/sleepiness during monotonous driving in train drivers. Physiol Meas 2018;39:105012. [PMID: 30251970 DOI: 10.1088/1361-6579/aae42e] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 2.0] [Reference Citation Analysis]
55 Lucza T, Ascherman Z, Kovács M, Makkos A, Harmat M, Juhász A, Janszky J, Komoly S, Kovács N, Dorn K, Karádi K. Comparing Sensitivity and Specificity of Addenbrooke's Cognitive Examination-I, III and Mini-Addenbrooke's Cognitive Examination in Parkinson's Disease. Behav Neurol 2018;2018:5932028. [PMID: 30369997 DOI: 10.1155/2018/5932028] [Cited by in Crossref: 3] [Cited by in F6Publishing: 5] [Article Influence: 0.6] [Reference Citation Analysis]
56 Wang Z, Jia X, Chen H, Feng T, Wang H. Abnormal Spontaneous Brain Activity in Early Parkinson's Disease With Mild Cognitive Impairment: A Resting-State fMRI Study. Front Physiol 2018;9:1093. [PMID: 30154730 DOI: 10.3389/fphys.2018.01093] [Cited by in Crossref: 28] [Cited by in F6Publishing: 30] [Article Influence: 5.6] [Reference Citation Analysis]
57 Hunt D, Stuart S, Nell J, Hausdorff JM, Galna B, Rochester L, Alcock L. Do people with Parkinson’s disease look at task relevant stimuli when walking? An exploration of eye movements. Behavioural Brain Research 2018;348:82-9. [DOI: 10.1016/j.bbr.2018.03.003] [Cited by in Crossref: 10] [Cited by in F6Publishing: 11] [Article Influence: 2.0] [Reference Citation Analysis]
58 Foley JA, Foltynie T, Limousin P, Cipolotti L. Standardised Neuropsychological Assessment for the Selection of Patients Undergoing DBS for Parkinson's Disease. Parkinsons Dis 2018;2018:4328371. [PMID: 29971141 DOI: 10.1155/2018/4328371] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 1.4] [Reference Citation Analysis]
59 Lange M, Heutte N, Noal S, Rigal O, Kurtz JE, Lévy C, Allouache D, Rieux C, Lefel J, Clarisse B, Leconte A, Veyret C, Barthélémy P, Longato N, Tron L, Castel H, Eustache F, Giffard B, Joly F. Cognitive Changes After Adjuvant Treatment in Older Adults with Early-Stage Breast Cancer. Oncologist 2019;24:62-8. [PMID: 29934409 DOI: 10.1634/theoncologist.2017-0570] [Cited by in Crossref: 18] [Cited by in F6Publishing: 19] [Article Influence: 3.6] [Reference Citation Analysis]
60 Bezdicek O, Červenková M, Moore TM, Stepankova Georgi H, Sulc Z, Wolk DA, Weintraub DA, Moberg PJ, Jech R, Kopecek M, Roalf DR. Determining a Short Form Montreal Cognitive Assessment (s-MoCA) Czech Version: Validity in Mild Cognitive Impairment Parkinson's Disease and Cross-Cultural Comparison. Assessment 2020;27:1960-70. [PMID: 29929376 DOI: 10.1177/1073191118778896] [Cited by in Crossref: 10] [Cited by in F6Publishing: 12] [Article Influence: 2.0] [Reference Citation Analysis]
61 Hogue O, Fernandez HH, Floden DP. Predicting early cognitive decline in newly-diagnosed Parkinson's patients: A practical model. Parkinsonism Relat Disord 2018;56:70-5. [PMID: 29936131 DOI: 10.1016/j.parkreldis.2018.06.031] [Cited by in Crossref: 14] [Cited by in F6Publishing: 11] [Article Influence: 2.8] [Reference Citation Analysis]
62 Chang HC, Lu CS, Chiou WD, Chen CC, Weng YH, Chang YJ. An 8-Week Low-Intensity Progressive Cycling Training Improves Motor Functions in Patients with Early-Stage Parkinson's Disease. J Clin Neurol 2018;14:225-33. [PMID: 29629527 DOI: 10.3988/jcn.2018.14.2.225] [Cited by in Crossref: 14] [Cited by in F6Publishing: 15] [Article Influence: 2.8] [Reference Citation Analysis]
63 Wong OW, Chan AY, Wong A, Lau CK, Yeung JH, Mok VC, Lam LC, Chan S. Eye movement parameters and cognitive functions in Parkinson's disease patients without dementia. Parkinsonism Relat Disord 2018;52:43-8. [PMID: 29571955 DOI: 10.1016/j.parkreldis.2018.03.013] [Cited by in Crossref: 10] [Cited by in F6Publishing: 8] [Article Influence: 2.0] [Reference Citation Analysis]
64 da Silva FC, Iop RDR, de Oliveira LC, Boll AM, de Alvarenga JGS, Gutierres Filho PJB, de Melo LMAB, Xavier AJ, da Silva R. Effects of physical exercise programs on cognitive function in Parkinson's disease patients: A systematic review of randomized controlled trials of the last 10 years. PLoS One 2018;13:e0193113. [PMID: 29486000 DOI: 10.1371/journal.pone.0193113] [Cited by in Crossref: 70] [Cited by in F6Publishing: 74] [Article Influence: 14.0] [Reference Citation Analysis]
65 Allone C, Lo Buono V, Corallo F, Bonanno L, Palmeri R, Di Lorenzo G, Marra A, Bramanti P, Marino S. Cognitive impairment in Parkinson's disease, Alzheimer's dementia, and vascular dementia: the role of the clock-drawing test. Psychogeriatrics 2018;18:123-31. [PMID: 29417704 DOI: 10.1111/psyg.12294] [Cited by in Crossref: 19] [Cited by in F6Publishing: 22] [Article Influence: 3.8] [Reference Citation Analysis]
66 Nackaerts E, Nieuwboer A, Broeder S, Swinnen S, Vandenberghe W, Heremans E. Altered effective connectivity contributes to micrographia in patients with Parkinson’s disease and freezing of gait. J Neurol 2018;265:336-47. [DOI: 10.1007/s00415-017-8709-3] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 1.7] [Reference Citation Analysis]
67 Alcock L, Galna B, Perkins R, Lord S, Rochester L. Step length determines minimum toe clearance in older adults and people with Parkinson's disease. J Biomech 2018;71:30-6. [PMID: 29429622 DOI: 10.1016/j.jbiomech.2017.12.002] [Cited by in Crossref: 27] [Cited by in F6Publishing: 28] [Article Influence: 4.5] [Reference Citation Analysis]
68 Skorvanek M, Goldman JG, Jahanshahi M, Marras C, Rektorova I, Schmand B, van Duijn E, Goetz CG, Weintraub D, Stebbins GT, Martinez-Martin P; members of the MDS Rating Scales Review Committee. Global scales for cognitive screening in Parkinson's disease: Critique and recommendations. Mov Disord 2018;33:208-18. [PMID: 29168899 DOI: 10.1002/mds.27233] [Cited by in Crossref: 91] [Cited by in F6Publishing: 94] [Article Influence: 15.2] [Reference Citation Analysis]
69 Gaßner H, Marxreiter F, Steib S, Kohl Z, Schlachetzki JCM, Adler W, Eskofier BM, Pfeifer K, Winkler J, Klucken J. Gait and Cognition in Parkinson's Disease: Cognitive Impairment Is Inadequately Reflected by Gait Performance during Dual Task. Front Neurol 2017;8:550. [PMID: 29123499 DOI: 10.3389/fneur.2017.00550] [Cited by in Crossref: 25] [Cited by in F6Publishing: 27] [Article Influence: 4.2] [Reference Citation Analysis]
70 Byun J, Lee BU, Kim M, Sunwoo J, Lim J, Moon J, Lee S, Jung K, Chu K, Kim M, Jeong MH, Cha KS, Choi JW, Kim KH, Lee SK, Jung K. Reduced P300 amplitude during a visuospatial attention task in idiopathic rapid eye movement sleep behavior disorder. Sleep Medicine 2017;38:78-84. [DOI: 10.1016/j.sleep.2017.06.037] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 1.5] [Reference Citation Analysis]
71 Gao Y, Nie K, Huang B, Mei M, Guo M, Xie S, Huang Z, Wang L, Zhao J, Zhang Y, Wang L. Changes of brain structure in Parkinson’s disease patients with mild cognitive impairment analyzed via VBM technology. Neuroscience Letters 2017;658:121-32. [DOI: 10.1016/j.neulet.2017.08.028] [Cited by in Crossref: 32] [Cited by in F6Publishing: 33] [Article Influence: 5.3] [Reference Citation Analysis]
72 Zeng Q, Dong X, Ruan C, Hu B, Zhou B, Xue Y, Liu Y, Yang H. Cognitive impairment in Chinese IIDDs revealed by MoCA and P300. Multiple Sclerosis and Related Disorders 2017;16:1-7. [DOI: 10.1016/j.msard.2017.05.006] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
73 Benge JF, Balsis S, Madeka T, Uhlman C, Lantrip C, Soileau MJ. Factor structure of the Montreal Cognitive Assessment items in a sample with early Parkinson's disease. Parkinsonism & Related Disorders 2017;41:104-8. [DOI: 10.1016/j.parkreldis.2017.05.023] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 1.0] [Reference Citation Analysis]
74 Brenkel M, Shulman K, Hazan E, Herrmann N, Owen AM. Assessing Capacity in the Elderly: Comparing the MoCA with a Novel Computerized Battery of Executive Function. Dement Geriatr Cogn Dis Extra 2017;7:249-56. [PMID: 28868068 DOI: 10.1159/000478008] [Cited by in Crossref: 11] [Cited by in F6Publishing: 12] [Article Influence: 1.8] [Reference Citation Analysis]
75 Barnish MS, Horton SMC, Butterfint ZR, Clark AB, Atkinson RA, Deane KHO. Speech and communication in Parkinson's disease: a cross-sectional exploratory study in the UK. BMJ Open 2017;7:e014642. [PMID: 28554918 DOI: 10.1136/bmjopen-2016-014642] [Cited by in Crossref: 14] [Cited by in F6Publishing: 31] [Article Influence: 2.3] [Reference Citation Analysis]
76 Prigatano GP, Souza LMN, Braga LW. Performance of a Brazilian sample on the Portuguese translation of the BNI Screen for Higher Cerebral Functions. J Clin Exp Neuropsychol 2018;40:173-82. [PMID: 28511576 DOI: 10.1080/13803395.2017.1325839] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
77 Lin VY, Chung J, Callahan BL, Smith L, Gritters N, Chen JM, Black SE, Masellis M. Development of cognitive screening test for the severely hearing impaired: Hearing-impaired MoCA. Laryngoscope 2017;127 Suppl 1:S4-S11. [PMID: 28409842 DOI: 10.1002/lary.26590] [Cited by in Crossref: 59] [Cited by in F6Publishing: 61] [Article Influence: 9.8] [Reference Citation Analysis]
78 De Coninck L, Bekkering GE, Bouckaert L, Declercq A, Graff MJL, Aertgeerts B. Home- and Community-Based Occupational Therapy Improves Functioning in Frail Older People: A Systematic Review. J Am Geriatr Soc 2017;65:1863-9. [PMID: 28369719 DOI: 10.1111/jgs.14889] [Cited by in Crossref: 37] [Cited by in F6Publishing: 41] [Article Influence: 6.2] [Reference Citation Analysis]
79 Roalf DR, Moore TM, Mechanic-Hamilton D, Wolk DA, Arnold SE, Weintraub DA, Moberg PJ. Bridging cognitive screening tests in neurologic disorders: A crosswalk between the short Montreal Cognitive Assessment and Mini-Mental State Examination. Alzheimers Dement 2017;13:947-52. [PMID: 28238740 DOI: 10.1016/j.jalz.2017.01.015] [Cited by in Crossref: 25] [Cited by in F6Publishing: 29] [Article Influence: 4.2] [Reference Citation Analysis]
80 Xue J, Chiu HFK, Liang J, Zhu T, Jiang Y, Chen S. Validation of the Six-Item Screener to screen for cognitive impairment in primary care settings in China. Aging Ment Health 2018;22:453-7. [PMID: 28145741 DOI: 10.1080/13607863.2017.1280768] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 1.0] [Reference Citation Analysis]
81 Larner AJ. The Usage of Cognitive Screening Instruments: Test Characteristics and Suspected Diagnosis. Cognitive Screening Instruments 2017. [DOI: 10.1007/978-3-319-44775-9_15] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 0.5] [Reference Citation Analysis]
82 Julayanont P, Nasreddine ZS. Montreal Cognitive Assessment (MoCA): Concept and Clinical Review. Cognitive Screening Instruments 2017. [DOI: 10.1007/978-3-319-44775-9_7] [Cited by in Crossref: 59] [Cited by in F6Publishing: 57] [Article Influence: 9.8] [Reference Citation Analysis]
83 Camargo CHF, Tolentino ES, Bronzini A, Ladeira MA, Lima R, Schultz-Pereira GL, Young-Blood MR. Comparison of the use of screening tools for evaluating cognitive impairment in patients with Parkinson's disease. Dement Neuropsychol 2016;10:344-50. [PMID: 29213480 DOI: 10.1590/s1980-5764-2016dn1004015] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.6] [Reference Citation Analysis]
84 Shen J, Anderson MC, Arehart KH, Souza PE. Using Cognitive Screening Tests in Audiology. Am J Audiol 2016;25:319-31. [PMID: 27788277 DOI: 10.1044/2016_AJA-16-0032] [Cited by in Crossref: 26] [Cited by in F6Publishing: 27] [Article Influence: 3.7] [Reference Citation Analysis]
85 Johnson PL, Potts GF, Sanchez-ramos J, Cimino CR. Self-reported impulsivity in Huntington’s disease patients and relationship to executive dysfunction and reward responsiveness. Journal of Clinical and Experimental Neuropsychology 2016;39:694-706. [DOI: 10.1080/13803395.2016.1257702] [Cited by in Crossref: 11] [Cited by in F6Publishing: 9] [Article Influence: 1.6] [Reference Citation Analysis]
86 van de Weijer SC, Duits AA, Bloem BR, Kessels RP, Jansen JF, Köhler S, Tissingh G, Kuijf ML. The Parkin'Play study: protocol of a phase II randomized controlled trial to assess the effects of a health game on cognition in Parkinson's disease. BMC Neurol 2016;16:209. [PMID: 27809791 DOI: 10.1186/s12883-016-0731-z] [Cited by in Crossref: 14] [Cited by in F6Publishing: 15] [Article Influence: 2.0] [Reference Citation Analysis]
87 Chen L, Yu C, Zhang N, Liu J, Liu W. Cognitive impairment in patients with Parkinson's disease: A 30-month follow-up study. Clin Neurol Neurosurg 2016;151:65-9. [PMID: 27816027 DOI: 10.1016/j.clineuro.2016.09.021] [Cited by in Crossref: 15] [Cited by in F6Publishing: 15] [Article Influence: 2.1] [Reference Citation Analysis]
88 Tumas V, Borges V, Ballalai-Ferraz H, Zabetian CP, Mata IF, Brito MMC, Foss MP, Novaretti N, Santos-Lobato BL. Some aspects of the validity of the Montreal Cognitive Assessment (MoCA) for evaluating cognitive impairment in Brazilian patients with Parkinson's disease. Dement Neuropsychol 2016;10:333-8. [PMID: 29213478 DOI: 10.1590/s1980-5764-2016dn1004013] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 1.3] [Reference Citation Analysis]
89 Van Liew C, Santoro MS, Goldstein J, Gluhm S, Gilbert PE, Corey-Bloom J. Evaluating Recall and Recognition Memory Using the Montreal Cognitive Assessment: Applicability for Alzheimer's and Huntington's Diseases. Am J Alzheimers Dis Other Demen 2016;31:658-63. [PMID: 27678491 DOI: 10.1177/1533317516668573] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.4] [Reference Citation Analysis]
90 Helmi L, Meagher D, O’Mahony E, O’Neill D, Mulligan O, Murthy S, McCarthy G, Adamis D. Agreement and conversion formula between mini-mental state examination and montreal cognitive assessment in an outpatient sample. World J Psychiatr 2016; 6(3): 358-364 [PMID: 27679776 DOI: 10.5498/wjp.v6.i3.358] [Cited by in CrossRef: 12] [Cited by in F6Publishing: 12] [Article Influence: 1.7] [Reference Citation Analysis]
91 Kim JI, Sunwoo MK, Sohn YH, Lee PH, Hong JY. The MMSE and MoCA for Screening Cognitive Impairment in Less Educated Patients with Parkinson's Disease. J Mov Disord 2016;9:152-9. [PMID: 27667187 DOI: 10.14802/jmd.16020] [Cited by in Crossref: 29] [Cited by in F6Publishing: 32] [Article Influence: 4.1] [Reference Citation Analysis]
92 Garcia-ptacek S, Kramberger MG. Parkinson Disease and Dementia. J Geriatr Psychiatry Neurol 2016;29:261-70. [DOI: 10.1177/0891988716654985] [Cited by in Crossref: 39] [Cited by in F6Publishing: 42] [Article Influence: 5.6] [Reference Citation Analysis]
93 Hayes HA, Hunsaker N, Dibble LE. Implicit Motor Sequence Learning in Individuals with Parkinson Disease: A Meta-Analysis. J Parkinsons Dis 2015;5:549-60. [PMID: 26406135 DOI: 10.3233/JPD-140441] [Cited by in Crossref: 19] [Cited by in F6Publishing: 20] [Article Influence: 2.7] [Reference Citation Analysis]
94 Fiorenzato E, Weis L, Falup-Pecurariu C, Diaconu S, Siri C, Reali E, Pezzoli G, Bisiacchi P, Antonini A, Biundo R. Montreal Cognitive Assessment (MoCA) and Mini-Mental State Examination (MMSE) performance in progressive supranuclear palsy and multiple system atrophy. J Neural Transm (Vienna) 2016;123:1435-42. [PMID: 27334897 DOI: 10.1007/s00702-016-1589-3] [Cited by in Crossref: 33] [Cited by in F6Publishing: 30] [Article Influence: 4.7] [Reference Citation Analysis]
95 King LA, Wilhelm J, Chen Y, Blehm R, Nutt J, Chen Z, Serdar A, Horak FB. Effects of Group, Individual, and Home Exercise in Persons With Parkinson Disease: A Randomized Clinical Trial. J Neurol Phys Ther 2015;39:204-12. [PMID: 26308937 DOI: 10.1097/NPT.0000000000000101] [Cited by in Crossref: 71] [Cited by in F6Publishing: 73] [Article Influence: 10.1] [Reference Citation Analysis]
96 Safarpour D, Willis AW. Clinical Epidemiology, Evaluation, and Management of Dementia in Parkinson Disease. Am J Alzheimers Dis Other Demen 2016;31:585-94. [PMID: 27295974 DOI: 10.1177/1533317516653823] [Cited by in Crossref: 12] [Cited by in F6Publishing: 13] [Article Influence: 1.7] [Reference Citation Analysis]
97 Cuenen A, Jongen EM, Brijs T, Brijs K, Lutin M, Van Vlierden K, Wets G. The relations between specific measures of simulated driving ability and functional ability: New insights for assessment and training programs of older drivers. Transportation Research Part F: Traffic Psychology and Behaviour 2016;39:65-78. [DOI: 10.1016/j.trf.2015.05.007] [Cited by in Crossref: 22] [Cited by in F6Publishing: 14] [Article Influence: 3.1] [Reference Citation Analysis]
98 Morris R, Lord S, Bunce J, Burn D, Rochester L. Gait and cognition: Mapping the global and discrete relationships in ageing and neurodegenerative disease. Neuroscience & Biobehavioral Reviews 2016;64:326-45. [DOI: 10.1016/j.neubiorev.2016.02.012] [Cited by in Crossref: 169] [Cited by in F6Publishing: 178] [Article Influence: 24.1] [Reference Citation Analysis]
99 Sobreira E, Pena-Pereira MA, Eckeli AL, Sobreira-Neto MA, Chagas MH, Foss MP, Cholerton B, Zabetian CP, Mata IF, Tumas V. Screening of cognitive impairment in patients with Parkinson's disease: diagnostic validity of the Brazilian versions of the Montreal Cognitive Assessment and the Addenbrooke's Cognitive Examination-Revised. Arq Neuropsiquiatr 2015;73:929-33. [PMID: 26517216 DOI: 10.1590/0004-282X20150156] [Cited by in Crossref: 19] [Cited by in F6Publishing: 19] [Article Influence: 2.7] [Reference Citation Analysis]
100 Utianski RL, Caviness JN, van Straaten EC, Beach TG, Dugger BN, Shill HA, Driver-Dunckley ED, Sabbagh MN, Mehta S, Adler CH, Hentz JG. Graph theory network function in Parkinson's disease assessed with electroencephalography. Clin Neurophysiol 2016;127:2228-36. [PMID: 27072094 DOI: 10.1016/j.clinph.2016.02.017] [Cited by in Crossref: 62] [Cited by in F6Publishing: 60] [Article Influence: 8.9] [Reference Citation Analysis]
101 Lees T, Lal S. Stress and its Impact on the Neurocognitive Performance of Australian Nurses: Stress and Cognition in Nurses. Stress Health 2017;33:45-54. [DOI: 10.1002/smi.2672] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 1.1] [Reference Citation Analysis]
102 Konstantopoulos K, Vogazianos P, Doskas T. Normative Data of the Montreal Cognitive Assessment in the Greek Population and Parkinsonian Dementia. Arch Clin Neuropsychol 2016;31:246-53. [PMID: 26891720 DOI: 10.1093/arclin/acw002] [Cited by in Crossref: 35] [Cited by in F6Publishing: 37] [Article Influence: 5.0] [Reference Citation Analysis]
103 Biundo R, Weis L, Bostantjopoulou S, Stefanova E, Falup-Pecurariu C, Kramberger MG, Geurtsen GJ, Antonini A, Weintraub D, Aarsland D. MMSE and MoCA in Parkinson's disease and dementia with Lewy bodies: a multicenter 1-year follow-up study. J Neural Transm (Vienna) 2016;123:431-8. [PMID: 26852137 DOI: 10.1007/s00702-016-1517-6] [Cited by in Crossref: 78] [Cited by in F6Publishing: 83] [Article Influence: 11.1] [Reference Citation Analysis]
104 Geschwind MD, Belkoura CR. The multidisciplinary evaluation of the atypical dementia patient. Non-Alzheimer's and Atypical Dementia 2016. [DOI: 10.1002/9781118797662.ch2] [Reference Citation Analysis]
105 Zhai Y, Chao Q, Li H, Wang B, Xu R, Wang N, Han Y, He X, Jia X, Wang X. Application and Revision of Montreal Cognitive Assessment in China's Military Retirees with Mild Cognitive Impairment. PLoS One 2016;11:e0145547. [PMID: 26727602 DOI: 10.1371/journal.pone.0145547] [Cited by in Crossref: 4] [Cited by in F6Publishing: 6] [Article Influence: 0.6] [Reference Citation Analysis]
106 Tremblay C, Monetta L, Langlois M, Schneider C. Intermittent Theta-Burst Stimulation of the Right Dorsolateral Prefrontal Cortex to Promote Metaphor Comprehension in Parkinson Disease: A Case Study. Archives of Physical Medicine and Rehabilitation 2016;97:74-83. [DOI: 10.1016/j.apmr.2015.09.002] [Cited by in Crossref: 9] [Cited by in F6Publishing: 5] [Article Influence: 1.3] [Reference Citation Analysis]
107 Lim PA, Mclean AM, Kilpatrick C, Deforge D, Iverson GL, Silverberg ND. Temporal stability and responsiveness of the Montreal Cognitive Assessment following acquired brain injury. Brain Injury 2015;30:29-35. [DOI: 10.3109/02699052.2015.1079732] [Cited by in Crossref: 13] [Cited by in F6Publishing: 14] [Article Influence: 1.6] [Reference Citation Analysis]
108 Alty JE, Cosgrove J, Jamieson S, Smith SL, Possin KL. Which figure copy test is more sensitive for cognitive impairment in Parkinson's disease: Wire cube or interlocking pentagons? Clin Neurol Neurosurg 2015;139:244-6. [PMID: 26519897 DOI: 10.1016/j.clineuro.2015.10.019] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 0.6] [Reference Citation Analysis]
109 Mestre TA, Beaulieu-Boire I, Aquino CC, Phielipp N, Poon YY, Lui JP, So J, Fox SH. What is a clinically important change in the Unified Dyskinesia Rating Scale in Parkinson's disease? Parkinsonism Relat Disord 2015;21:1349-54. [PMID: 26439944 DOI: 10.1016/j.parkreldis.2015.09.044] [Cited by in Crossref: 18] [Cited by in F6Publishing: 13] [Article Influence: 2.3] [Reference Citation Analysis]
110 Coleman RR, Ostrem JL. Patient selection. Deep Brain Stimulation Management 2015. [DOI: 10.1017/cbo9781316026625.003] [Reference Citation Analysis]
111 Goldman JG, Weintraub D. Advances in the treatment of cognitive impairment in Parkinson's disease: Treatment of Cognitive Impairment in PD. Mov Disord 2015;30:1471-89. [DOI: 10.1002/mds.26352] [Cited by in Crossref: 55] [Cited by in F6Publishing: 57] [Article Influence: 6.9] [Reference Citation Analysis]
112 Cui D, Wang J, Bian Z, Li Q, Wang L, Li X. Analysis of entropies based on empirical mode decomposition in amnesic mild cognitive impairment of diabetes mellitus. J Innov Opt Health Sci 2015;08:1550010. [DOI: 10.1142/s1793545815500108] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 1.3] [Reference Citation Analysis]
113 Coen RF, Robertson DA, Kenny RA, King-kallimanis BL. Strengths and Limitations of the MoCA for Assessing Cognitive Functioning: Findings From a Large Representative Sample of Irish Older Adults. J Geriatr Psychiatry Neurol 2016;29:18-24. [DOI: 10.1177/0891988715598236] [Cited by in Crossref: 38] [Cited by in F6Publishing: 40] [Article Influence: 4.8] [Reference Citation Analysis]
114 Bocanegra Y, García AM, Pineda D, Buriticá O, Villegas A, Lopera F, Gómez D, Gómez-arias C, Cardona JF, Trujillo N, Ibáñez A. Syntax, action verbs, action semantics, and object semantics in Parkinson's disease: Dissociability, progression, and executive influences. Cortex 2015;69:237-54. [DOI: 10.1016/j.cortex.2015.05.022] [Cited by in Crossref: 99] [Cited by in F6Publishing: 118] [Article Influence: 12.4] [Reference Citation Analysis]
115 Kestenbaum M, Ford B, Louis ED. Estimating the Proportion of Essential Tremor and Parkinson's Disease Patients Undergoing Deep Brain Stimulation Surgery: Five-Year Data From Columbia University Medical Center (2009-2014). Mov Disord Clin Pract 2015;2:384-7. [PMID: 28845438 DOI: 10.1002/mdc3.12185] [Cited by in Crossref: 19] [Cited by in F6Publishing: 20] [Article Influence: 2.4] [Reference Citation Analysis]
116 Brown DS, Bernstein IH, McClintock SM, Munro Cullum C, Dewey RB Jr, Husain M, Lacritz LH. Use of the Montreal Cognitive Assessment and Alzheimer's Disease-8 as cognitive screening measures in Parkinson's disease. Int J Geriatr Psychiatry 2016;31:264-72. [PMID: 26177715 DOI: 10.1002/gps.4320] [Cited by in Crossref: 16] [Cited by in F6Publishing: 16] [Article Influence: 2.0] [Reference Citation Analysis]
117 Vogel SJ, Banks SJ, Cummings JL, Miller JB. Concordance of the Montreal cognitive assessment with standard neuropsychological measures. Alzheimers Dement (Amst) 2015;1:289-94. [PMID: 27239512 DOI: 10.1016/j.dadm.2015.05.002] [Cited by in Crossref: 36] [Cited by in F6Publishing: 43] [Article Influence: 4.5] [Reference Citation Analysis]
118 Jalili M. Hemispheric asymmetry of electroencephalography-based functional brain networks. Neuroreport 2014;25:1266-71. [PMID: 25191924 DOI: 10.1097/WNR.0000000000000256] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 1.1] [Reference Citation Analysis]
119 Tang H, Huang J, Nie K, Gan R, Wang L, Zhao J, Huang Z, Zhang Y, Wang L. Cognitive profile of Parkinson's disease patients: a comparative study between early-onset and late-onset Parkinson's disease. International Journal of Neuroscience 2015;126:227-34. [DOI: 10.3109/00207454.2015.1010646] [Cited by in Crossref: 18] [Cited by in F6Publishing: 19] [Article Influence: 2.3] [Reference Citation Analysis]
120 Rossetti HC, Weiner M, Hynan LS, Cullum CM, Khera A, Lacritz LH. Subclinical atherosclerosis and subsequent cognitive function. Atherosclerosis 2015;241:36-41. [PMID: 25957568 DOI: 10.1016/j.atherosclerosis.2015.04.813] [Cited by in Crossref: 20] [Cited by in F6Publishing: 23] [Article Influence: 2.5] [Reference Citation Analysis]
121 van der Kolk NM, Overeem S, de Vries NM, Kessels RP, Donders R, Brouwer M, Berg D, Post B, Bloem BR. Design of the Park-in-Shape study: a phase II double blind randomized controlled trial evaluating the effects of exercise on motor and non-motor symptoms in Parkinson's disease. BMC Neurol 2015;15:56. [PMID: 25880966 DOI: 10.1186/s12883-015-0312-6] [Cited by in Crossref: 21] [Cited by in F6Publishing: 22] [Article Influence: 2.6] [Reference Citation Analysis]
122 Gratwicke J, Jahanshahi M, Foltynie T. Parkinson's disease dementia: a neural networks perspective. Brain 2015;138:1454-76. [PMID: 25888551 DOI: 10.1093/brain/awv104] [Cited by in Crossref: 275] [Cited by in F6Publishing: 282] [Article Influence: 34.4] [Reference Citation Analysis]
123 Yin Z, Zhao Y, Lu X, Duan H. A hybrid intelligent diagnosis approach for quick screening of Alzheimer's disease based on multiple neuropsychological rating scales. Comput Math Methods Med 2015;2015:258761. [PMID: 25815043 DOI: 10.1155/2015/258761] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.6] [Reference Citation Analysis]
124 Janssen MA, Bosch M, Koopmans PP, Kessels RP. Validity of the Montreal Cognitive Assessment and the HIV Dementia Scale in the assessment of cognitive impairment in HIV-1 infected patients. J Neurovirol 2015;21:383-90. [PMID: 25678141 DOI: 10.1007/s13365-015-0324-4] [Cited by in Crossref: 33] [Cited by in F6Publishing: 36] [Article Influence: 4.1] [Reference Citation Analysis]
125 Chung EJ, Seok K, Kim SJ. A comparison of montreal cognitive assessment between patients with visual hallucinations and without visual hallucinations in Parkinson's disease. Clin Neurol Neurosurg 2015;130:98-100. [PMID: 25596487 DOI: 10.1016/j.clineuro.2014.12.022] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.5] [Reference Citation Analysis]
126 吴 心. The Research Status of Mild Cognitive Impairment in the Elderly. AR 2015;02:1-5. [DOI: 10.12677/ar.2015.21001] [Reference Citation Analysis]
127 Herman T, Weiss A, Brozgol M, Wilf-yarkoni A, Giladi N, Hausdorff JM. Cognitive function and other non-motor features in non-demented Parkinson’s disease motor subtypes. J Neural Transm 2015;122:1115-24. [DOI: 10.1007/s00702-014-1349-1] [Cited by in Crossref: 28] [Cited by in F6Publishing: 24] [Article Influence: 3.1] [Reference Citation Analysis]
128 Abdolahi A, Bull MT, Darwin KC, Venkataraman V, Grana MJ, Dorsey ER, Biglan KM. A feasibility study of conducting the Montreal Cognitive Assessment remotely in individuals with movement disorders. Health Informatics J 2016;22:304-11. [PMID: 25391849 DOI: 10.1177/1460458214556373] [Cited by in Crossref: 57] [Cited by in F6Publishing: 59] [Article Influence: 6.3] [Reference Citation Analysis]
129 van Steenoven I, Aarsland D, Hurtig H, Chen-Plotkin A, Duda JE, Rick J, Chahine LM, Dahodwala N, Trojanowski JQ, Roalf DR. Conversion between mini-mental state examination, montreal cognitive assessment, and dementia rating scale-2 scores in Parkinson’s disease. Mov Disord. 2014;29:1809-1815. [PMID: 25381961 DOI: 10.1002/mds.26062] [Cited by in Crossref: 64] [Cited by in F6Publishing: 67] [Article Influence: 7.1] [Reference Citation Analysis]
130 Tiffin-Richards FE, Costa AS, Holschbach B, Frank RD, Vassiliadou A, Krüger T, Kuckuck K, Gross T, Eitner F, Floege J, Schulz JB, Reetz K. The Montreal Cognitive Assessment (MoCA) - a sensitive screening instrument for detecting cognitive impairment in chronic hemodialysis patients. PLoS One 2014;9:e106700. [PMID: 25347578 DOI: 10.1371/journal.pone.0106700] [Cited by in Crossref: 98] [Cited by in F6Publishing: 108] [Article Influence: 10.9] [Reference Citation Analysis]
131 Kandiah N, Zhang A, Cenina AR, Au WL, Nadkarni N, Tan LC. Montreal Cognitive Assessment for the screening and prediction of cognitive decline in early Parkinson's disease. Parkinsonism Relat Disord 2014;20:1145-8. [PMID: 25176439 DOI: 10.1016/j.parkreldis.2014.08.002] [Cited by in Crossref: 59] [Cited by in F6Publishing: 52] [Article Influence: 6.6] [Reference Citation Analysis]
132 King LA, Priest KC, Nutt J, Chen Y, Chen Z, Melnick M, Horak F. Comorbidity and functional mobility in persons with Parkinson disease. Arch Phys Med Rehabil 2014;95:2152-7. [PMID: 25102383 DOI: 10.1016/j.apmr.2014.07.396] [Cited by in Crossref: 31] [Cited by in F6Publishing: 32] [Article Influence: 3.4] [Reference Citation Analysis]
133 Burdick DJ, Cholerton B, Watson GS, Siderowf A, Trojanowski JQ, Weintraub D, Ritz B, Rhodes SL, Rausch R, Factor SA, Wood-Siverio C, Quinn JF, Chung KA, Srivatsal S, Edwards KL, Montine TJ, Zabetian CP, Leverenz JB. People with Parkinson's disease and normal MMSE score have a broad range of cognitive performance. Mov Disord 2014;29:1258-64. [PMID: 25073717 DOI: 10.1002/mds.25924] [Cited by in Crossref: 45] [Cited by in F6Publishing: 49] [Article Influence: 5.0] [Reference Citation Analysis]
134 Chen L, Yu C, Fu X, Liu W, Hua P, Zhang N, Kuo S. Using the Montreal Cognitive Assessment Scale to screen for dementia in Chinese patients with Parkinson's Disease. Shanghai Arch Psychiatry 2013;25:296-305. [PMID: 24991170 DOI: 10.3969/j.issn.1002-0829.2013.05.005] [Cited by in F6Publishing: 6] [Reference Citation Analysis]
135 Kurata T, Hatanaka N, Morimoto N, Deguchi S, Deguchi K, Ikeda Y, Abe K. Pulsion severity showed a good correlation with cognitive function in Parkinson’s disease. Neurological Research 2014;36:962-7. [DOI: 10.1179/1743132814y.0000000384] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.4] [Reference Citation Analysis]
136 Schwarzschild MA, Ascherio A, Beal MF, Cudkowicz ME, Curhan GC, Hare JM, Hooper DC, Kieburtz KD, Macklin EA, Oakes D, Rudolph A, Shoulson I, Tennis MK, Espay AJ, Gartner M, Hung A, Bwala G, Lenehan R, Encarnacion E, Ainslie M, Castillo R, Togasaki D, Barles G, Friedman JH, Niles L, Carter JH, Murray M, Goetz CG, Jaglin J, Ahmed A, Russell DS, Cotto C, Goudreau JL, Russell D, Parashos SA, Ede P, Saint-Hilaire MH, Thomas CA, James R, Stacy MA, Johnson J, Gauger L, Antonelle de Marcaida J, Thurlow S, Isaacson SH, Carvajal L, Rao J, Cook M, Hope-Porche C, McClurg L, Grasso DL, Logan R, Orme C, Ross T, Brocht AF, Constantinescu R, Sharma S, Venuto C, Weber J, Eaton K; Parkinson Study Group SURE-PD Investigators. Inosine to increase serum and cerebrospinal fluid urate in Parkinson disease: a randomized clinical trial. JAMA Neurol 2014;71:141-50. [PMID: 24366103 DOI: 10.1001/jamaneurol.2013.5528] [Cited by in Crossref: 160] [Cited by in F6Publishing: 172] [Article Influence: 17.8] [Reference Citation Analysis]
137 Bezdicek O, Nikolai T, Hoskovcová M, Štochl J, Brožová H, Dušek P, Zárubová K, Jech R, Růžička E. Grooved Pegboard Predicates More of Cognitive Than Motor Involvement in Parkinson’s Disease. Assessment 2014;21:723-30. [DOI: 10.1177/1073191114524271] [Cited by in Crossref: 23] [Cited by in F6Publishing: 27] [Article Influence: 2.6] [Reference Citation Analysis]
138 Ohta K, Osada T, Shinohara Y, Suzuki N, Takahashi K, Seki M, Nihei Y, Iwasawa S, Gotoh J, Yamaguchi K, Komatsumoto S, Isozumi K, Kobari M, Mihara B, Morita Y, Yasutomi D, Gotoh K, Muramatsu K, Shirai T, Tomita Y, Sato H, the Keio Parkinson's Disease Database. Comparing the Montreal Cognitive Assessment with Mini-Mental State Examination in Japanese Parkinson's disease patients. Neurol Clin Neurosci 2014;2:44-49. [DOI: 10.1111/ncn3.80] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.2] [Reference Citation Analysis]
139 Murray DK, Sacheli MA, Eng JJ, Stoessl AJ. The effects of exercise on cognition in Parkinson's disease: a systematic review. Transl Neurodegener 2014;3:5. [PMID: 24559472 DOI: 10.1186/2047-9158-3-5] [Cited by in Crossref: 96] [Cited by in F6Publishing: 131] [Article Influence: 10.7] [Reference Citation Analysis]
140 Ozdilek B, Kenangil G. Validation of the Turkish Version of the Montreal Cognitive Assessment Scale (MoCA-TR) in Patients With Parkinson’s Disease. The Clinical Neuropsychologist 2014;28:333-43. [DOI: 10.1080/13854046.2014.881554] [Cited by in Crossref: 42] [Cited by in F6Publishing: 36] [Article Influence: 4.7] [Reference Citation Analysis]
141 Tanner CM, Meng CC, Ravina B, Lang A, Kurlan R, Marek K, Oakes D, Seibyl J, Flagg E, Gauger L, Guest DD, Goetz CG, Kieburtz K, DiEuliis D, Fahn S, Elliott RA, Shoulson I. A practical approach to remote longitudinal follow-up of Parkinson's disease: the FOUND study. Mov Disord 2014;29:743-9. [PMID: 24515275 DOI: 10.1002/mds.25814] [Cited by in Crossref: 10] [Cited by in F6Publishing: 13] [Article Influence: 1.1] [Reference Citation Analysis]
142 Martinez-martin P, Rodriguez-blazquez C, Forjaz MJ, Chaudhuri KR. Cognition and Neuropsychiatric Symptoms. Guide to Assessment Scales in Parkinson’s Disease 2014. [DOI: 10.1007/978-1-907673-88-7_7] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
143 Martinez-martin P. Nonmotor symptoms and health-related quality of life in early Parkinson's disease: NONMOTOR SYMPTOMS AND HRQOL IN PD. Mov Disord 2014;29:166-8. [DOI: 10.1002/mds.25799] [Cited by in Crossref: 17] [Cited by in F6Publishing: 19] [Article Influence: 1.7] [Reference Citation Analysis]
144 Sasai T, Matsuura M, Inoue Y. Electroencephalographic findings related with mild cognitive impairment in idiopathic rapid eye movement sleep behavior disorder. Sleep 2013;36:1893-9. [PMID: 24293764 DOI: 10.5665/sleep.3224] [Cited by in Crossref: 34] [Cited by in F6Publishing: 36] [Article Influence: 3.4] [Reference Citation Analysis]
145 Neikrug AB, Maglione JE, Liu L, Natarajan L, Avanzino JA, Corey-Bloom J, Palmer BW, Loredo JS, Ancoli-Israel S. Effects of sleep disorders on the non-motor symptoms of Parkinson disease. J Clin Sleep Med 2013;9:1119-29. [PMID: 24235892 DOI: 10.5664/jcsm.3148] [Cited by in Crossref: 72] [Cited by in F6Publishing: 80] [Article Influence: 7.2] [Reference Citation Analysis]
146 de Guise E, Leblanc J, Champoux M, Couturier C, Alturki AY, Lamoureux J, Desjardins M, Marcoux J, Maleki M, Feyz M. The mini-mental state examination and the montreal cognitive assessment after traumatic brain injury: An early predictive study. Brain Injury 2013;27:1428-34. [DOI: 10.3109/02699052.2013.835867] [Cited by in Crossref: 27] [Cited by in F6Publishing: 27] [Article Influence: 2.7] [Reference Citation Analysis]
147 Ihara M, Okamoto Y, Hase Y, Takahashi R. Association of Physical Activity with the Visuospatial/Executive Functions of the Montreal Cognitive Assessment in Patients with Vascular Cognitive Impairment. Journal of Stroke and Cerebrovascular Diseases 2013;22:e146-51. [DOI: 10.1016/j.jstrokecerebrovasdis.2012.10.007] [Cited by in Crossref: 18] [Cited by in F6Publishing: 17] [Article Influence: 1.8] [Reference Citation Analysis]
148 Galioto R, Garcia S, Spitznagel MB, Strain G, Devlin M, Crosby RD, Mitchell JE, Gunstad J. The Mini-Mental State Exam (MMSE) is not sensitive to cognitive impairment in bariatric surgery candidates. Surg Obes Relat Dis 2014;10:553-7. [PMID: 24355321 DOI: 10.1016/j.soard.2013.09.010] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.5] [Reference Citation Analysis]
149 Gluhm S, Goldstein J, Loc K, Colt A, Liew CV, Corey-Bloom J. Cognitive performance on the mini-mental state examination and the montreal cognitive assessment across the healthy adult lifespan. Cogn Behav Neurol 2013;26:1-5. [PMID: 23538566 DOI: 10.1097/WNN.0b013e31828b7d26] [Cited by in Crossref: 72] [Cited by in F6Publishing: 76] [Article Influence: 7.2] [Reference Citation Analysis]
150 Zhang LT, Zhang SX, Wu SD. Electroencephalogram analysis: an early diagnostic method for assessing cognitive impairment after cerebral hemorrhage. Clin EEG Neurosci 2014;45:92-7. [PMID: 24004490 DOI: 10.1177/1550059413488107] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
151 Diagnosis and biomarkers. Neuropsychiatric and Cognitive Changes in Parkinson's Disease and Related Movement Disorders 2013. [DOI: 10.1017/cbo9781139856669.006] [Reference Citation Analysis]
152 Gluhm S, Goldstein J, Brown D, Van Liew C, Gilbert PE, Corey-Bloom J. Usefulness of the Montreal Cognitive Assessment (MoCA) in Huntington's disease. Mov Disord 2013;28:1744-7. [PMID: 23798501 DOI: 10.1002/mds.25578] [Cited by in Crossref: 24] [Cited by in F6Publishing: 25] [Article Influence: 2.4] [Reference Citation Analysis]
153 Murakami H, Fujita K, Futamura A, Sugimoto A, Kobayakawa M, Kezuka M, Midorikawa A, Kawamura M. The Montreal Cognitive Assessment and Neurobehavioral Cognitive Status Examination are useful for screening mild cognitive impairment in Japanese patients with Parkinson's disease. Neurol Clin Neurosci 2013;1:103-8. [DOI: 10.1111/j.2049-4173.2013.00032.x] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 1.0] [Reference Citation Analysis]
154 Wong GK, Lam SW, Wong A, Ngai K, Poon WS, Mok V. Comparison of montreal cognitive assessment and mini-mental state examination in evaluating cognitive domain deficit following aneurysmal subarachnoid haemorrhage. PLoS One. 2013;8:e59946. [PMID: 23573223 DOI: 10.1371/journal.pone.0059946] [Cited by in Crossref: 41] [Cited by in F6Publishing: 45] [Article Influence: 4.1] [Reference Citation Analysis]
155 Wong GKC, Ngai K, Lam SW, Wong A, Mok V, Poon WS. Validity of the Montreal Cognitive Assessment for traumatic brain injury patients with intracranial haemorrhage. Brain Injury 2013;27:394-8. [DOI: 10.3109/02699052.2012.750746] [Cited by in Crossref: 28] [Cited by in F6Publishing: 29] [Article Influence: 2.8] [Reference Citation Analysis]
156 Moafmashhadi P, Koski L. Limitations for Interpreting Failure on Individual Subtests of the Montreal Cognitive Assessment. J Geriatr Psychiatry Neurol 2013;26:19-28. [DOI: 10.1177/0891988712473802] [Cited by in Crossref: 34] [Cited by in F6Publishing: 37] [Article Influence: 3.4] [Reference Citation Analysis]
157 Ko H, Kim J, Kim H, Jang Y, Chung H. Construction validity of the MoCA-K to MMSE-K, LOTCA-G in the Community living Elderly. Journal of the Korea Academia-Industrial cooperation Society 2013;14:312-20. [DOI: 10.5762/kais.2013.14.1.312] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.5] [Reference Citation Analysis]
158 Robbins RN, Joska JA, Thomas KG, Stein DJ, Linda T, Mellins CA, Remien RH. Exploring the utility of the Montreal Cognitive Assessment to detect HIV-associated neurocognitive disorder: the challenge and need for culturally valid screening tests in South Africa. Clin Neuropsychol 2013;27:437-54. [PMID: 23336183 DOI: 10.1080/13854046.2012.759627] [Cited by in Crossref: 36] [Cited by in F6Publishing: 30] [Article Influence: 3.6] [Reference Citation Analysis]
159 Sikaroodi H, Yadegari S, Miri SR. Cognitive impairments in patients with cerebrovascular risk factors: a comparison of Mini Mental Status Exam and Montreal Cognitive Assessment. Clin Neurol Neurosurg 2013;115:1276-80. [PMID: 23290422 DOI: 10.1016/j.clineuro.2012.11.026] [Cited by in Crossref: 12] [Cited by in F6Publishing: 15] [Article Influence: 1.2] [Reference Citation Analysis]
160 Larner AJ. Conclusion: Place of Cognitive Screening Instruments: Test Characteristics and Suspected Diagnosis. Cognitive Screening Instruments 2013. [DOI: 10.1007/978-1-4471-2452-8_12] [Cited by in Crossref: 3] [Article Influence: 0.3] [Reference Citation Analysis]
161 Julayanont P, Phillips N, Chertkow H, Nasreddine ZS. Montreal Cognitive Assessment (MoCA): Concept and Clinical Review. Cognitive Screening Instruments 2013. [DOI: 10.1007/978-1-4471-2452-8_6] [Cited by in Crossref: 50] [Cited by in F6Publishing: 50] [Article Influence: 5.0] [Reference Citation Analysis]
162 Wishart S, Macphee GJ. Evaluation and management of the non-motor features of Parkinson's disease. Ther Adv Chronic Dis 2011;2:69-85. [PMID: 23251743 DOI: 10.1177/2040622310387847] [Cited by in Crossref: 16] [Cited by in F6Publishing: 16] [Article Influence: 1.5] [Reference Citation Analysis]
163 Watson GS, Cholerton BA, Gross RG, Weintraub D, Zabetian CP, Trojanowski JQ, Montine TJ, Siderowf A, Leverenz JB. Neuropsychologic assessment in collaborative Parkinson's disease research: a proposal from the National Institute of Neurological Disorders and Stroke Morris K. Udall Centers of Excellence for Parkinson's Disease Research at the University of Pennsylvania and the University of Washington. Alzheimers Dement 2013;9:609-14. [PMID: 23164549 DOI: 10.1016/j.jalz.2012.07.006] [Cited by in Crossref: 20] [Cited by in F6Publishing: 23] [Article Influence: 1.8] [Reference Citation Analysis]
164 Wang Y, Zhang X, Huang J, Zhu M, Guan Q, Liu C. Associations Between EEG Beta Power Abnormality and Diagnosis in Cognitive Impairment Post Cerebral Infarcts. J Mol Neurosci 2013;49:632-8. [DOI: 10.1007/s12031-012-9918-y] [Cited by in Crossref: 18] [Cited by in F6Publishing: 18] [Article Influence: 1.6] [Reference Citation Analysis]
165 Crizzle AM, Classen S, Bédard M, Lanford D, Winter S. MMSE as a predictor of on-road driving performance in community dwelling older drivers. Accident Analysis & Prevention 2012;49:287-92. [DOI: 10.1016/j.aap.2012.02.003] [Cited by in Crossref: 31] [Cited by in F6Publishing: 32] [Article Influence: 2.8] [Reference Citation Analysis]
166 Macphee GJ, Stewart DA. Parkinson's disease: treatment and non-motor features. Rev Clin Gerontol 2012;22:243-260. [DOI: 10.1017/s0959259812000093] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.3] [Reference Citation Analysis]
167 Bezdicek O, Majerova V, Novak M, Nikolai T, Ruzicka E, Roth J. Validity of the Montreal Cognitive Assessment in the Detection of Cognitive Dysfunction in Huntington's Disease. Applied Neuropsychology: Adult 2012;20:33-40. [DOI: 10.1080/09084282.2012.670158] [Cited by in Crossref: 26] [Cited by in F6Publishing: 24] [Article Influence: 2.4] [Reference Citation Analysis]
168 Poston KL. Overview of rare movement disorders. Continuum (Minneap Minn) 2010;16:49-76. [PMID: 22810180 DOI: 10.1212/01.CON.0000348900.09963.bc] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.1] [Reference Citation Analysis]
169 Nie K, Zhang Y, Wang L, Zhao J, Huang Z, Gan R, Li S, Wang L. A pilot study of psychometric properties of the Beijing version of Montreal Cognitive Assessment in patients with idiopathic Parkinson's disease in China. J Clin Neurosci 2012;19:1497-500. [PMID: 22959678 DOI: 10.1016/j.jocn.2011.11.039] [Cited by in Crossref: 31] [Cited by in F6Publishing: 33] [Article Influence: 2.8] [Reference Citation Analysis]
170 Lessig S, Nie D, Xu R, Corey-Bloom J. Changes on brief cognitive instruments over time in Parkinson's disease. Mov Disord 2012;27:1125-8. [PMID: 22692724 DOI: 10.1002/mds.25070] [Cited by in Crossref: 50] [Cited by in F6Publishing: 53] [Article Influence: 4.5] [Reference Citation Analysis]
171 Galvin JE. OPTIMIZING DIAGNOSIS AND MANANGEMENT IN MILD-TO-MODERATE ALZHEIMER'S DISEASE. Neurodegener Dis Manag 2012;2:291-304. [PMID: 22973426 DOI: 10.2217/nmt.12.21] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 0.6] [Reference Citation Analysis]
172 Pontone GM, Palanci J, Williams JR, Bassett SS. Screening for DSM-IV-TR cognitive disorder NOS in Parkinson's disease using the Mattis Dementia Rating Scale. Int J Geriatr Psychiatry 2013;28:364-71. [PMID: 22628158 DOI: 10.1002/gps.3833] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 0.7] [Reference Citation Analysis]
173 O'donnell M, Teo K, Gao P, Anderson C, Sleight P, Dans A, Marzona I, Bosch J, Probstfield J, Yusuf S. Cognitive impairment and risk of cardiovascular events and mortality. European Heart Journal 2012;33:1777-86. [DOI: 10.1093/eurheartj/ehs053] [Cited by in Crossref: 88] [Cited by in F6Publishing: 93] [Article Influence: 8.0] [Reference Citation Analysis]
174 Cameron J, Worrall-Carter L, Page K, Stewart S, Ski CF. Screening for mild cognitive impairment in patients with heart failure: Montreal cognitive assessment versus mini mental state exam. Eur J Cardiovasc Nurs 2013;12:252-60. [PMID: 22514141 DOI: 10.1177/1474515111435606] [Cited by in Crossref: 84] [Cited by in F6Publishing: 89] [Article Influence: 7.6] [Reference Citation Analysis]
175 McNeill A, Duran R, Proukakis C, Bras J, Hughes D, Mehta A, Hardy J, Wood NW, Schapira AH. Hyposmia and cognitive impairment in Gaucher disease patients and carriers. Mov Disord 2012;27:526-32. [PMID: 22344629 DOI: 10.1002/mds.24945] [Cited by in Crossref: 79] [Cited by in F6Publishing: 85] [Article Influence: 7.2] [Reference Citation Analysis]
176 Ihara M, Okamoto Y, Takahashi R. Suitability of the Montreal cognitive assessment versus the mini-mental state examination in detecting vascular cognitive impairment. J Stroke Cerebrovasc Dis. 2013;22:737-741. [PMID: 22306380 DOI: 10.1016/j.jstrokecerebrovasdis.2012.01.001] [Cited by in Crossref: 30] [Cited by in F6Publishing: 35] [Article Influence: 2.7] [Reference Citation Analysis]
177 Larner AJ. Cognitive Assessment. Dementia in Clinical Practice: A Neurological Perspective 2012. [DOI: 10.1007/978-1-4471-2377-4_2] [Reference Citation Analysis]
178 Stewart S, O'riley A, Edelstein B, Gould C. A Preliminary Comparison of Three Cognitive Screening Instruments in Long Term Care: The MMSE, SLUMS, and MoCA. Clinical Gerontologist 2012;35:57-75. [DOI: 10.1080/07317115.2011.626515] [Cited by in Crossref: 30] [Cited by in F6Publishing: 13] [Article Influence: 2.7] [Reference Citation Analysis]
179 Zhao J, Tang H, Sun J, Wang B, Chen S, Fu Y. Analysis of cognitive dysfunction with silent cerebral infarction: a prospective study in Chinese patients. Metab Brain Dis 2012;27:17-22. [PMID: 22193539 DOI: 10.1007/s11011-011-9275-5] [Cited by in Crossref: 20] [Cited by in F6Publishing: 19] [Article Influence: 1.7] [Reference Citation Analysis]
180 Larner AJ. Screening utility of the Montreal Cognitive Assessment (MoCA): in place of – or as well as – the MMSE? Int Psychogeriatr 2012;24:391-6. [DOI: 10.1017/s1041610211001839] [Cited by in Crossref: 149] [Cited by in F6Publishing: 154] [Article Influence: 12.4] [Reference Citation Analysis]
181 You JS, Chen RZ, Zhang FM, Zhou ZY, Cai YF, Li GF. The chinese (cantonese) montreal cognitive assessment in patients with subcortical ischemic vascular dementia. Dement Geriatr Cogn Dis Extra 2011;1:276-82. [PMID: 22545038 DOI: 10.1159/000331238] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 0.7] [Reference Citation Analysis]
182 Martinic Popovic I, Lovrencic-huzjan A, Simundic A, Popovic A, Seric V, Demarin V. Cognitive Performance in Asymptomatic Patients With Advanced Carotid Disease. Cognitive and Behavioral Neurology 2011;24:145-51. [DOI: 10.1097/wnn.0b013e3182313020] [Cited by in Crossref: 31] [Cited by in F6Publishing: 36] [Article Influence: 2.6] [Reference Citation Analysis]
183 Sweet L, Van Adel M, Metcalf V, Wright L, Harley A, Leiva R, Taler V. The Montreal Cognitive Assessment (MoCA) in geriatric rehabilitation: psychometric properties and association with rehabilitation outcomes. Int Psychogeriatr 2011;23:1582-91. [DOI: 10.1017/s1041610211001451] [Cited by in Crossref: 32] [Cited by in F6Publishing: 34] [Article Influence: 2.7] [Reference Citation Analysis]
184 Litvan I, Aarsland D, Adler CH, Goldman JG, Kulisevsky J, Mollenhauer B, Rodriguez-Oroz MC, Tröster AI, Weintraub D. MDS Task Force on mild cognitive impairment in Parkinson's disease: critical review of PD-MCI. Mov Disord 2011;26:1814-24. [PMID: 21661055 DOI: 10.1002/mds.23823] [Cited by in Crossref: 516] [Cited by in F6Publishing: 574] [Article Influence: 43.0] [Reference Citation Analysis]
185 Shanker V, Groves M, Heiman G, Palmese C, Saunders-Pullman R, Ozelius L, Raymond D, Bressman S. Mood and cognition in leucine-rich repeat kinase 2 G2019S Parkinson's disease. Mov Disord 2011;26:1875-80. [PMID: 21611978 DOI: 10.1002/mds.23746] [Cited by in Crossref: 27] [Cited by in F6Publishing: 30] [Article Influence: 2.3] [Reference Citation Analysis]
186 Toglia J, Fitzgerald KA, O'dell MW, Mastrogiovanni AR, Lin CD. The Mini-Mental State Examination and Montreal Cognitive Assessment in Persons With Mild Subacute Stroke: Relationship to Functional Outcome. Archives of Physical Medicine and Rehabilitation 2011;92:792-8. [DOI: 10.1016/j.apmr.2010.12.034] [Cited by in Crossref: 125] [Cited by in F6Publishing: 159] [Article Influence: 10.4] [Reference Citation Analysis]
187 Villeneuve S, Rodrigues-Brazète J, Joncas S, Postuma RB, Latreille V, Gagnon JF. Validity of the Mattis Dementia Rating Scale to detect mild cognitive impairment in Parkinson's disease and REM sleep behavior disorder. Dement Geriatr Cogn Disord 2011;31:210-7. [PMID: 21474929 DOI: 10.1159/000326212] [Cited by in Crossref: 39] [Cited by in F6Publishing: 40] [Article Influence: 3.3] [Reference Citation Analysis]
188 Chou KL, Amick MM, Brandt J, Camicioli R, Frei K, Gitelman D, Goldman J, Growdon J, Hurtig HI, Levin B, Litvan I, Marsh L, Simuni T, Tröster AI, Uc EY; Parkinson Study Group Cognitive/Psychiatric Working Group. A recommended scale for cognitive screening in clinical trials of Parkinson's disease. Mov Disord 2010;25:2501-7. [PMID: 20878991 DOI: 10.1002/mds.23362] [Cited by in Crossref: 122] [Cited by in F6Publishing: 126] [Article Influence: 10.2] [Reference Citation Analysis]
189 Damian AM, Jacobson SA, Hentz JG, Belden CM, Shill HA, Sabbagh MN, Caviness JN, Adler CH. The Montreal Cognitive Assessment and the Mini-Mental State Examination as Screening Instruments for Cognitive Impairment: Item Analyses and Threshold Scores. Dement Geriatr Cogn Disord 2011;31:126-31. [DOI: 10.1159/000323867] [Cited by in Crossref: 160] [Cited by in F6Publishing: 173] [Article Influence: 13.3] [Reference Citation Analysis]
190 Fahn S, Jankovic J, Hallett M. Parkinsonism. Principles and Practice of Movement Disorders. Elsevier; 2011. pp. 66-92. [DOI: 10.1016/b978-1-4377-2369-4.00004-4] [Cited by in Crossref: 5] [Article Influence: 0.4] [Reference Citation Analysis]
191 Komadina NC, Terpening Z, Huang Y, Halliday GM, Naismith SL, Lewis SJ. Utility and Limitations of Addenbrooke’s Cognitive Examination-Revised for Detecting Mild Cognitive Impairment in Parkinson’s Disease. Dement Geriatr Cogn Disord 2011;31:349-57. [DOI: 10.1159/000328165] [Cited by in Crossref: 24] [Cited by in F6Publishing: 24] [Article Influence: 2.0] [Reference Citation Analysis]
192 Frommelt P, Leidner O, Specht U. Neurologische Erkrankungen. Sozialmedizinische Begutachtung für die gesetzliche Rentenversicherung 2011. [DOI: 10.1007/978-3-642-10251-6_23] [Reference Citation Analysis]
193 Baxter MF, Dulworth AN, Smith TM. Identification of mild cognitive impairments in cancer survivors. Occup Ther Health Care 2011;25:26-37. [PMID: 23898981 DOI: 10.3109/07380577.2010.533251] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 0.7] [Reference Citation Analysis]
194 Ostrem JL. Patient selection. Deep Brain Stimulation Management 2010. [DOI: 10.1017/cbo9780511763281.003] [Reference Citation Analysis]
195 Hanna-Pladdy B, Enslein A, Fray M, Gajewski BJ, Pahwa R, Lyons KE. Utility of the NeuroTrax computerized battery for cognitive screening in Parkinson's disease: comparison with the MMSE and the MoCA. Int J Neurosci 2010;120:538-43. [PMID: 20615057 DOI: 10.3109/00207454.2010.496539] [Cited by in Crossref: 19] [Cited by in F6Publishing: 21] [Article Influence: 1.5] [Reference Citation Analysis]
196 Gómez-Esteban JC, Tijero B, Somme J, Ciordia R, Berganzo K, Rouco I, Bustos JL, Valle MA, Lezcano E, Zarranz JJ. Impact of psychiatric symptoms and sleep disorders on the quality of life of patients with Parkinson's disease. J Neurol 2011;258:494-9. [PMID: 20957384 DOI: 10.1007/s00415-010-5786-y] [Cited by in Crossref: 81] [Cited by in F6Publishing: 76] [Article Influence: 6.2] [Reference Citation Analysis]
197 Dujardin K, Dubois B, Tison F, Durif F, Bourdeix I, Péré J, Duhamel A; for the EXECUTIVE study group. Parkinson's disease dementia can be easily detected in routine clinical practice: Screening for Parkinson's Disease Dementia. Mov Disord 2010;25:2769-76. [DOI: 10.1002/mds.23391] [Cited by in Crossref: 32] [Cited by in F6Publishing: 34] [Article Influence: 2.5] [Reference Citation Analysis]
198 Mickes L, Jacobson M, Peavy G, Wixted JT, Lessig S, Goldstein JL, Corey-bloom J. A comparison of two brief screening measures of cognitive impairment in Huntington's disease. Mov Disord 2010;25:2229-33. [DOI: 10.1002/mds.23181] [Cited by in Crossref: 35] [Cited by in F6Publishing: 38] [Article Influence: 2.7] [Reference Citation Analysis]
199 Gagnon JF, Postuma RB, Joncas S, Desjardins C, Latreille V. The Montreal Cognitive Assessment: a screening tool for mild cognitive impairment in REM sleep behavior disorder. Mov Disord 2010;25:936-40. [PMID: 20310038 DOI: 10.1002/mds.23079] [Cited by in Crossref: 53] [Cited by in F6Publishing: 57] [Article Influence: 4.1] [Reference Citation Analysis]
200 Pendlebury ST, Cuthbertson FC, Welch SJ, Mehta Z, Rothwell PM. Underestimation of cognitive impairment by Mini-Mental State Examination versus the Montreal Cognitive Assessment in patients with transient ischemic attack and stroke: a population-based study. Stroke 2010;41:1290-3. [PMID: 20378863 DOI: 10.1161/STROKEAHA.110.579888] [Cited by in Crossref: 313] [Cited by in F6Publishing: 333] [Article Influence: 24.1] [Reference Citation Analysis]
201 Cameron J, Worrall-Carter L, Page K, Riegel B, Lo SK, Stewart S. Does cognitive impairment predict poor self-care in patients with heart failure? Eur J Heart Fail 2010;12:508-15. [PMID: 20354031 DOI: 10.1093/eurjhf/hfq042] [Cited by in Crossref: 197] [Cited by in F6Publishing: 210] [Article Influence: 15.2] [Reference Citation Analysis]
202 Nieuwenhuis-Mark RE. The death knoll for the MMSE: has it outlived its purpose? J Geriatr Psychiatry Neurol. 2010;23:151-157. [PMID: 20231732 DOI: 10.1177/0891988710363714] [Cited by in Crossref: 91] [Cited by in F6Publishing: 96] [Article Influence: 7.0] [Reference Citation Analysis]
203 Siddiqui MS, Haq IU, Okun MS. DEEP BRAIN STIMULATION IN MOVEMENT DISORDERS: . CONTINUUM: Lifelong Learning in Neurology 2010;16:110-30. [DOI: 10.1212/01.con.0000348903.94715.b4] [Cited by in Crossref: 6] [Cited by in F6Publishing: 9] [Article Influence: 0.5] [Reference Citation Analysis]
204 Videnovic A, Bernard B, Fan W, Jaglin J, Leurgans S, Shannon KM. The Montreal Cognitive Assessment as a screening tool for cognitive dysfunction in Huntington's disease: MoCA in HD. Mov Disord 2010;25:401-4. [DOI: 10.1002/mds.22748] [Cited by in Crossref: 56] [Cited by in F6Publishing: 58] [Article Influence: 4.3] [Reference Citation Analysis]
205 Ravina B, Tanner C, Dieuliis D, Eberly S, Flagg E, Galpern WR, Fahn S, Goetz CG, Grate S, Kurlan R, Lang AE, Marek K, Kieburtz K, Oakes D, Elliott R, Shoulson I; Parkinson Study Group LABS-PD Investigators. A longitudinal program for biomarker development in Parkinson's disease: a feasibility study. Mov Disord 2009;24:2081-90. [PMID: 19691116 DOI: 10.1002/mds.22690] [Cited by in Crossref: 44] [Cited by in F6Publishing: 46] [Article Influence: 3.4] [Reference Citation Analysis]
206 Mast BT, Gerstenecker A. Screening Instruments and Brief Batteries for Dementia. Handbook of Assessment in Clinical Gerontology 2010. [DOI: 10.1016/b978-0-12-374961-1.10019-3] [Cited by in Crossref: 17] [Cited by in F6Publishing: 17] [Article Influence: 1.3] [Reference Citation Analysis]
207 Gould C, Edelstein BA, Ciliberti C. Older Adults. Diagnostic Interviewing 2010. [DOI: 10.1007/978-1-4419-1320-3_20] [Reference Citation Analysis]
208 Hoops S, Nazem S, Siderowf AD, Duda JE, Xie SX, Stern MB, Weintraub D. Validity of the MoCA and MMSE in the detection of MCI and dementia in Parkinson disease. Neurology 2009;73:1738-45. [PMID: 19933974 DOI: 10.1212/WNL.0b013e3181c34b47] [Cited by in Crossref: 668] [Cited by in F6Publishing: 719] [Article Influence: 47.7] [Reference Citation Analysis]
209 Copersino ML, Fals-Stewart W, Fitzmaurice G, Schretlen DJ, Sokoloff J, Weiss RD. Rapid cognitive screening of patients with substance use disorders. Exp Clin Psychopharmacol 2009;17:337-44. [PMID: 19803633 DOI: 10.1037/a0017260] [Cited by in Crossref: 101] [Cited by in F6Publishing: 108] [Article Influence: 7.2] [Reference Citation Analysis]
210 Duro D, Simões MR, Ponciano E, Santana I. Validation studies of the Portuguese experimental version of the Montreal Cognitive Assessment (MoCA): confirmatory factor analysis. J Neurol 2010;257:728-34. [DOI: 10.1007/s00415-009-5399-5] [Cited by in Crossref: 59] [Cited by in F6Publishing: 53] [Article Influence: 4.2] [Reference Citation Analysis]
211 Kulisevsky J, Pagonabarraga J. Cognitive impairment in Parkinson's disease: tools for diagnosis and assessment. Mov Disord 2009;24:1103-10. [PMID: 19353727 DOI: 10.1002/mds.22506] [Cited by in Crossref: 128] [Cited by in F6Publishing: 138] [Article Influence: 9.1] [Reference Citation Analysis]
212 Dujardin K, Duhamel A, Delliaux M, Thomas-antérion C, Destée A, Defebvre L. Cognitive complaints in Parkinson’s disease: its relationship with objective cognitive decline. J Neurol 2010;257:79-84. [DOI: 10.1007/s00415-009-5268-2] [Cited by in Crossref: 41] [Cited by in F6Publishing: 42] [Article Influence: 2.9] [Reference Citation Analysis]
213 Harvey PD, Ferris SH, Cummings JL, Wesnes KA, Hsu C, Lane RM, Tekin S. Evaluation of dementia rating scales in Parkinson's disease dementia. Am J Alzheimers Dis Other Demen 2010;25:142-8. [PMID: 19359706 DOI: 10.1177/1533317509333904] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 0.9] [Reference Citation Analysis]
214 Koski L, Xie H, Finch L. Measuring cognition in a geriatric outpatient clinic: Rasch analysis of the Montreal Cognitive Assessment. J Geriatr Psychiatry Neurol 2009;22:151-60. [PMID: 19307324 DOI: 10.1177/0891988709332944] [Cited by in Crossref: 40] [Cited by in F6Publishing: 44] [Article Influence: 2.9] [Reference Citation Analysis]
215 Tan EK, Jankovic J. Patient Selection for Surgery for Parkinson’s Disease. Textbook of Stereotactic and Functional Neurosurgery 2009. [DOI: 10.1007/978-3-540-69960-6_91] [Cited by in Crossref: 1] [Article Influence: 0.1] [Reference Citation Analysis]
216 Nazem S, Siderowf AD, Duda JE, Have TT, Colcher A, Horn SS, Moberg PJ, Wilkinson JR, Hurtig HI, Stern MB, Weintraub D. Montreal cognitive assessment performance in patients with Parkinson's disease with "normal" global cognition according to mini-mental state examination score. J Am Geriatr Soc 2009;57:304-8. [PMID: 19170786 DOI: 10.1111/j.1532-5415.2008.02096.x] [Cited by in Crossref: 210] [Cited by in F6Publishing: 228] [Article Influence: 14.0] [Reference Citation Analysis]
217 Mamikonyan E, Moberg PJ, Siderowf A, Duda JE, Have TT, Hurtig HI, Stern MB, Weintraub D. Mild cognitive impairment is common in Parkinson's disease patients with normal Mini-Mental State Examination (MMSE) scores. Parkinsonism Relat Disord 2009;15:226-31. [PMID: 18595765 DOI: 10.1016/j.parkreldis.2008.05.006] [Cited by in Crossref: 124] [Cited by in F6Publishing: 142] [Article Influence: 8.3] [Reference Citation Analysis]
218 Bruna O, Subirana J, Villalta V, Virgili C, Junqué C. Alteraciones neuropsicológicas y de la fluencia verbal en la Enfermedad de Parkinson. Revista de Logopedia, Foniatría y Audiología 2008;28:8-14. [DOI: 10.1016/s0214-4603(08)70041-x] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.3] [Reference Citation Analysis]